Tag Archives: liver disease

August, 2018

April, 2018

November, 2016

  • 11 November

    FDA Approves Gilead’s Vemlidy for Treatment of Hepatitis B

    FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Vemlidy has a boxed warning in its product label …

March, 2015